TY  - GEN
AU  - van Brummelen,Emilie M J
AU  - Levchenko,Evgeny
AU  - Dómine,Manuel
AU  - Fennell,Dean A
AU  - Kindler,Hedy L
AU  - Viteri,Santiago
AU  - Gadgeel,Shirish
AU  - López,Pilar Garrido
AU  - Kostorov,Vladimir
AU  - Morgensztern,Daniel
AU  - Orlov,Sergey
AU  - Zauderer,Marjorie G
AU  - Vansteenkiste,Johan F
AU  - Baker-Neblett,Katherine
AU  - Vasquez,James
AU  - Wang,Xiaowei
AU  - Bellovin,David I
AU  - Schellens,Jan H M
AU  - Yan,Li
AU  - Mitrica,Ionel
AU  - DeYoung,M Phillip
AU  - Trigo,José
TI  - A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma
SN  - 1573-0646
PY  - 2021///0303
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cisplatin
KW  - Female
KW  - Fibroblast Growth Factor 2
KW  - metabolism
KW  - Humans
KW  - Immunoglobulin G
KW  - Ligands
KW  - Male
KW  - Mesothelioma, Malignant
KW  - drug therapy
KW  - Middle Aged
KW  - Oncogene Proteins, Fusion
KW  - Pemetrexed
KW  - Receptor, Fibroblast Growth Factor, Type 1
KW  - Recombinant Fusion Proteins
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10637-019-00783-7
ER  -